News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellular Biomedicine Group (CBMG) Raises $10 Million In Private Placement


7/16/2014 1:54:05 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cellular Biomedicine Group of California raised $10 million through a private placement led by Hong Kong investment banker Francis Leung. CBMG is a cell therapy company that is developing three products for the China market. For serving as lead investor, Mr. Leung has a three-year option to buy an additional 1 million shares at $8 each. If the stock trades above $12 for 20 consecutive trading days, CBMG has the right to compel the purchase. That may happen soon.

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES